JP3197600004
JP3197600004
ONO PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 1.06T EUR | 1.11T EUR |
Enterprise Value | 964.91B EUR | 1.11T EUR |
Valuation Multiples | ||
Trailing P/E | 13.93x | -- |
Forward P/E | 13.36x | -- |
Price to Sales | 2.1x | -- |
Price to Book | 1.22x | -- |
EV/Revenue | 1.91x | -- |
EV/EBITDA | 6.97x | -- |
Price to FCF (P/FCF) | 8.81x | -- |
EV/FCF | 8.01x | -- |
FCF Yield | 11.35% | -- |